The Hill  |  September 3, 2021

“I do think that the White House will not have as smooth a path through the FDA as they think on boosters,” said Lawrence Gostin, a professor of global health law at Georgetown University Law.

“The scientific community is clearly not in lockstep behind them. President Biden got ahead of his public health agencies,” Gostin said.

Read more here.